aluates Reports

$ 0.0

Automative

Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Research Report 2026

Published Date: 2026-01-22

Report Code: QYRE-Auto-1Z18907

Global Proteolysis Targeting Chimera PROTAC Development and Manufacturing Services Market Research Report 2024

BUY CHAPTERS

Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Research Report 2026

Code: QYRE-Auto-1Z18907

Report

2026-01-22

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

WuXi AppTec

Syngene International Limited

Charles River Laboratories

Aurigene Pharmaceutical Services Ltd.

Boc Sciences

BPS Bioscience

Bio-Techne

Apeloa Pharmaceutical Co.,Ltd.

Creative-Biolabs

Veranova, L.P.

Aganitha AI Inc.

Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size

The global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services market was valued at US$ 537 million in 2025 and is anticipated to reach US$ 1026 million by 2032, at a CAGR of 9.8% from 2026 to 2032.

Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market

Proteolysis Targeting Chimeras (PROTACs) are a series of hetero-bifunctional molecules that hijack the body’s own natural disposal system to initiate selective degradation of the protein of interest (POI). PROTACs have the potential to overcome most of the limitations of small molecule inhibitors, and they offer several advantages of the traditional concepts of drug discovery.

The North American market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services in Targeted Protein Degradation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services include WuXi AppTec, Syngene International Limited, Charles River Laboratories, Veranova, L.P., Aurigene Pharmaceutical Services Ltd, BOC Sciences, BPS Bioscience, Bio-Techne, Apeloa Pharmaceutical Co. Ltd., Aganitha AI Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services. The Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Report

Report Metric	Details
Report Name	Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market
Accounted market size in 2025	US$ 537 million
Forecasted market size in 2032	US$ 1026 million
CAGR	9.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	PROTACs Targeting Protein Kinases PROTACs Targeting Nuclear Receptors PROTACs Targeting BET Proteins PROTACs Targeting Additional Protein
Segment by Application	Targeted Protein Degradation Drug Discovery Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	WuXi AppTec, Syngene International Limited, Charles River Laboratories, Veranova, L.P., Aurigene Pharmaceutical Services Ltd, BOC Sciences, BPS Bioscience, Bio-Techne, Apeloa Pharmaceutical Co. Ltd., Aganitha AI Inc., Creative Biolabs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market growing?

Ans: The Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market witnessing a CAGR of 9.8% during the forecast period 2026-2032.

What is the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market size in 2032?

Ans: The Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market size in 2032 will be US$ 1026 million.

Who are the main players in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report?

Ans: The main players in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market are WuXi AppTec, Syngene International Limited, Charles River Laboratories, Veranova, L.P., Aurigene Pharmaceutical Services Ltd, BOC Sciences, BPS Bioscience, Bio-Techne, Apeloa Pharmaceutical Co. Ltd., Aganitha AI Inc., Creative Biolabs

What are the Application segmentation covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report?

Ans: The Applications covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report are Targeted Protein Degradation, Drug Discovery, Other

What are the Type segmentation covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report?

Ans: The Types covered in the Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market report are PROTACs Targeting Protein Kinases, PROTACs Targeting Nuclear Receptors, PROTACs Targeting BET Proteins, PROTACs Targeting Additional Protein

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 PROTACs Targeting Protein Kinases

1.2.3 PROTACs Targeting Nuclear Receptors

1.2.4 PROTACs Targeting BET Proteins

1.2.5 PROTACs Targeting Additional Protein

1.3 Market by Application

1.3.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Targeted Protein Degradation

1.3.3 Drug Discovery

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Perspective (2021–2032)

2.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Growth Trends by Region

2.2.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Historic Market Size by Region (2021–2026)

2.2.3 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Region (2027–2032)

2.3 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Dynamics

2.3.1 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Industry Trends

2.3.2 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Drivers

2.3.3 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Challenges

2.3.4 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players by Revenue

3.1.1 Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players by Revenue (2021–2026)

3.1.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue

3.4 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Concentration Ratio

3.4.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue in 2025

3.5 Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Head Offices and Areas Served

3.6 Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Products and Applications

3.7 Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Breakdown Data by Type

4.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Historic Market Size by Type (2021–2026)

4.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Type (2027–2032)

5 Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Breakdown Data by Application

5.1 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Historic Market Size by Application (2021–2026)

5.2 Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2021–2032)

6.2 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2021–2026)

6.4 North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2021–2032)

7.2 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2021–2026)

7.4 Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2021–2032)

8.2 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2021–2032)

9.2 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2021–2026)

9.4 Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (2021–2032)

10.2 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 WuXi AppTec

11.1.1 WuXi AppTec Company Details

11.1.2 WuXi AppTec Business Overview

11.1.3 WuXi AppTec Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.1.4 WuXi AppTec Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.1.5 WuXi AppTec Recent Development

11.2 Syngene International Limited

11.2.1 Syngene International Limited Company Details

11.2.2 Syngene International Limited Business Overview

11.2.3 Syngene International Limited Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.2.4 Syngene International Limited Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.2.5 Syngene International Limited Recent Development

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Details

11.3.2 Charles River Laboratories Business Overview

11.3.3 Charles River Laboratories Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.3.4 Charles River Laboratories Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.3.5 Charles River Laboratories Recent Development

11.4 Veranova, L.P.

11.4.1 Veranova, L.P. Company Details

11.4.2 Veranova, L.P. Business Overview

11.4.3 Veranova, L.P. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.4.4 Veranova, L.P. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.4.5 Veranova, L.P. Recent Development

11.5 Aurigene Pharmaceutical Services Ltd

11.5.1 Aurigene Pharmaceutical Services Ltd Company Details

11.5.2 Aurigene Pharmaceutical Services Ltd Business Overview

11.5.3 Aurigene Pharmaceutical Services Ltd Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.5.4 Aurigene Pharmaceutical Services Ltd Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.5.5 Aurigene Pharmaceutical Services Ltd Recent Development

11.6 BOC Sciences

11.6.1 BOC Sciences Company Details

11.6.2 BOC Sciences Business Overview

11.6.3 BOC Sciences Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.6.4 BOC Sciences Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.6.5 BOC Sciences Recent Development

11.7 BPS Bioscience

11.7.1 BPS Bioscience Company Details

11.7.2 BPS Bioscience Business Overview

11.7.3 BPS Bioscience Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.7.4 BPS Bioscience Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.7.5 BPS Bioscience Recent Development

11.8 Bio-Techne

11.8.1 Bio-Techne Company Details

11.8.2 Bio-Techne Business Overview

11.8.3 Bio-Techne Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.8.4 Bio-Techne Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.8.5 Bio-Techne Recent Development

11.9 Apeloa Pharmaceutical Co. Ltd.

11.9.1 Apeloa Pharmaceutical Co. Ltd. Company Details

11.9.2 Apeloa Pharmaceutical Co. Ltd. Business Overview

11.9.3 Apeloa Pharmaceutical Co. Ltd. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.9.4 Apeloa Pharmaceutical Co. Ltd. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.9.5 Apeloa Pharmaceutical Co. Ltd. Recent Development

11.10 Aganitha AI Inc.

11.10.1 Aganitha AI Inc. Company Details

11.10.2 Aganitha AI Inc. Business Overview

11.10.3 Aganitha AI Inc. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.10.4 Aganitha AI Inc. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.10.5 Aganitha AI Inc. Recent Development

11.11 Creative Biolabs

11.11.1 Creative Biolabs Company Details

11.11.2 Creative Biolabs Business Overview

11.11.3 Creative Biolabs Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Introduction

11.11.4 Creative Biolabs Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

11.11.5 Creative Biolabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

WuXi AppTec

Syngene International Limited

Charles River Laboratories

Aurigene Pharmaceutical Services Ltd.

Boc Sciences

BPS Bioscience

Bio-Techne

Apeloa Pharmaceutical Co.,Ltd.

Creative-Biolabs

Veranova, L.P.

Aganitha AI Inc.

List of Tables

Table 1. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of PROTACs Targeting Protein Kinases

Table 3. Key Players of PROTACs Targeting Nuclear Receptors

Table 4. Key Players of PROTACs Targeting BET Proteins

Table 5. Key Players of PROTACs Targeting Additional Protein

Table 6. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (US$ Million), 2021–2026

Table 9. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region (2021–2026)

Table 10. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region (2027–2032)

Table 12. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Trends

Table 13. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Drivers

Table 14. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Challenges

Table 15. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Restraints

Table 16. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue by Players (US$ Million), 2021–2026

Table 17. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Players (2021–2026)

Table 18. Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue, 2025

Table 19. Ranking of Global Top Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Headquarters and Area Served

Table 22. Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Products and Applications

Table 23. Global Key Players of Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Type (US$ Million), 2021–2026

Table 26. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Type (2021–2026)

Table 27. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Type (2027–2032)

Table 29. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Application (US$ Million), 2021–2026

Table 30. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Application (2021–2026)

Table 31. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue Market Share by Application (2027–2032)

Table 33. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2021–2026

Table 35. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Country (US$ Million), 2027–2032

Table 48. WuXi AppTec Company Details

Table 49. WuXi AppTec Business Overview

Table 50. WuXi AppTec Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 51. WuXi AppTec Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 52. WuXi AppTec Recent Development

Table 53. Syngene International Limited Company Details

Table 54. Syngene International Limited Business Overview

Table 55. Syngene International Limited Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 56. Syngene International Limited Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 57. Syngene International Limited Recent Development

Table 58. Charles River Laboratories Company Details

Table 59. Charles River Laboratories Business Overview

Table 60. Charles River Laboratories Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 61. Charles River Laboratories Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 62. Charles River Laboratories Recent Development

Table 63. Veranova, L.P. Company Details

Table 64. Veranova, L.P. Business Overview

Table 65. Veranova, L.P. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 66. Veranova, L.P. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 67. Veranova, L.P. Recent Development

Table 68. Aurigene Pharmaceutical Services Ltd Company Details

Table 69. Aurigene Pharmaceutical Services Ltd Business Overview

Table 70. Aurigene Pharmaceutical Services Ltd Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 71. Aurigene Pharmaceutical Services Ltd Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 72. Aurigene Pharmaceutical Services Ltd Recent Development

Table 73. BOC Sciences Company Details

Table 74. BOC Sciences Business Overview

Table 75. BOC Sciences Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 76. BOC Sciences Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 77. BOC Sciences Recent Development

Table 78. BPS Bioscience Company Details

Table 79. BPS Bioscience Business Overview

Table 80. BPS Bioscience Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 81. BPS Bioscience Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 82. BPS Bioscience Recent Development

Table 83. Bio-Techne Company Details

Table 84. Bio-Techne Business Overview

Table 85. Bio-Techne Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 86. Bio-Techne Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 87. Bio-Techne Recent Development

Table 88. Apeloa Pharmaceutical Co. Ltd. Company Details

Table 89. Apeloa Pharmaceutical Co. Ltd. Business Overview

Table 90. Apeloa Pharmaceutical Co. Ltd. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 91. Apeloa Pharmaceutical Co. Ltd. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 92. Apeloa Pharmaceutical Co. Ltd. Recent Development

Table 93. Aganitha AI Inc. Company Details

Table 94. Aganitha AI Inc. Business Overview

Table 95. Aganitha AI Inc. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 96. Aganitha AI Inc. Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 97. Aganitha AI Inc. Recent Development

Table 98. Creative Biolabs Company Details

Table 99. Creative Biolabs Business Overview

Table 100. Creative Biolabs Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Product

Table 101. Creative Biolabs Revenue in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (US$ Million), 2021–2026

Table 102. Creative Biolabs Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Picture

Figure 2. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Type: 2025 vs 2032

Figure 4. PROTACs Targeting Protein Kinases Features

Figure 5. PROTACs Targeting Nuclear Receptors Features

Figure 6. PROTACs Targeting BET Proteins Features

Figure 7. PROTACs Targeting Additional Protein Features

Figure 8. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Application: 2025 vs 2032

Figure 10. Targeted Protein Degradation Case Studies

Figure 11. Drug Discovery Case Studies

Figure 12. Other Case Studies

Figure 13. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Report Years Considered

Figure 14. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region: 2025 vs 2032

Figure 17. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Players in 2025

Figure 18. Global Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Revenue in 2025

Figure 20. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2021–2032)

Figure 22. United States Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2021–2032)

Figure 26. Germany Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Region (2021–2032)

Figure 34. China Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2021–2032)

Figure 42. Mexico Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Share by Country (2021–2032)

Figure 46. Israel Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. WuXi AppTec Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 50. Syngene International Limited Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 51. Charles River Laboratories Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 52. Veranova, L.P. Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 53. Aurigene Pharmaceutical Services Ltd Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 54. BOC Sciences Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 55. BPS Bioscience Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 56. Bio-Techne Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 57. Apeloa Pharmaceutical Co. Ltd. Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 58. Aganitha AI Inc. Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 59. Creative Biolabs Revenue Growth Rate in Proteolysis Targeting Chimera (PROTAC) Development and Manufacturing Services Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User